Publication | Closed Access

Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis

Liver FibrosisImmunologyCell DeathPathologyCirrhosisOxidative StressFulminant HepatitisViral HepatitisHepatotoxicityAntisense TherapyAutoimmune DiseaseLiver PhysiologyHepatology InflammationCell BiologyDrug-induced Liver InjuryHepatologyLiver Fas ExpressionHepatitisAntisense Oligonucleotide ProtectsLiver DiseaseMedicine